Evaluating Cell Viability After Cryopreservation
Hawkins, B. J., Abazari, A., Mathew, Aby. J. Evaluating Cell Viability After Cryopreservation. PDA Letter. July 2018.
Read MoreTag: T cells
SV-BR-1-GM, A Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses An Immune Signature And Directly Activates CD4+ T Lymphocytes
Lacher, M. D., Bauer, G., Fury, B., Graeve, S., Fledderman, E. L., Petrie, T. D., Coleal-Bergum, D. P., Hackett, T., Perotti, N. H., Kong, Y. Y., Kwok, W. W., Wagner, J. P., Wiseman, C. L., Williams, W. V. SV-BR-1-GM, A Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses An Immune Signature And Directly Activates CD4+…
Read MoreDelineating the Critical Process Parameters for Cell Therapy Cryopreservation
Delineating the Critical Process Parameters for Cell Therapy Cryopreservation
Read MoreHigh fidelity hypothermic preservation of primary tissues in organ transplant preservative for single cell transcriptome analysis
Wang, Penland, Gokce, Croote, Quake. High fidelity hypothermic preservation of primary tissues in organ transplant preservative for single cell transcriptome analysis. BMC Genomics (2018) 19:140. https://doi.org/10.1186/s12864-018-4512-5
Read MoreA Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
Henrieta Fraser, Niloufar Safinia ,Nathali Grageda, Sarah Thirkell, Katie Lowe, Laura J. Fry, Cristiano Scottá, Andrew Hope, Christopher Fisher, Rachel Hilton, David Game, Paul Harden, Andrew Bushell, Kathryn Wood, Robert I. Lechler, Giovanna Lombardi. A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. Molecular Therapy: Methods & Clinical Development 2018…
Read MoreLym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti Tumor Effects against B-Cell Lymphoma
Zheng, Hu, Wolfe, Gonsalves, Ren, Khawli, Kaslow, Epstein. Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti Tumor Effects against B-Cell Lymphoma. Int. J. Mol. Sci. 2017, 18, 2773. doi:10.3390/ijms18122773
Read MoreRegional Delivery of Chimeric Antigen Receptor– Engineered T Cells Effectively Targets HER2þ Breast Cancer Metastasis to the Brain
Princeman, Tilakawardane, Jeang, Aguilar, Murad, Park, Chang, Ostberg, Neman, Jandial, Portnow, Forman, Brown. Regional Delivery of Chimeric Antigen Receptor– Engineered T Cells Effectively Targets HER2þ Breast Cancer Metastasis to the Brain. Clin Cancer Res. 2017 Oct 23. doi: 10.1158/1078-0432.CCR-17-2041
Read MoreBest Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C
Fink J, Abazari A, Hawkins B, Albert M, O’Donnell K, Mathew A. Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C. Biopreservation and Biobanking Volume 15, Number 3, 2017. DOI:10.1089=bio.2017.29021.abstracts
Read MoreCryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage
Cryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage
Read MorePathologically expanded peripheral T helper cell subsets drives B cells in rheumatoid arthritis
Rao, Gurish, Marshall, Slowikowski, Fonseka, Liu, Donlin, Henderson, Wei, MizoGuchi, Teslovich, Weinblatt, Massarotti, Coblyn, Helfgott, Lee, Todd, Bykerk, Goodman, Pernis, Ivashkiv, Karlson, Nigrovic, Filer, Buckley, Lederer, Raychaudhuri, Brenner. Pathologically expanded peripheral T helper cell subsets drives B cells in rheumatoid arthritis. Nature 542, 110–114 (02 February 2017) doi:10.1038/nature20810
Read More